Fish oil and arthritis drug tested against aggressive breast cancer in young women
NCT ID NCT01881048
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested whether two anti-inflammatory drugs—fish oil (omega-3 fatty acid) and celecoxib (Celebrex)—could reduce inflammation and slow cancer growth in women aged 18-50 with pregnancy-associated breast cancer. The 42 participants took one of the drugs for at least a week before their planned surgery. The main goal was to measure changes in a tumor growth marker called Ki-67, gathering data to help design larger future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- omega-3 fatty acid (fish oil) and celecoxib
- What this could lead to
- If successful, this could point toward a way to reduce inflammation in pregnancy-associated breast cancer, potentially improving treatment options for this aggressive form of the disease.
- What could go wrong
- This is a very early, small study (42 participants) designed mainly to gather preliminary data, not to prove effectiveness. The results may not lead to a direct treatment, and the drugs may not show a meaningful effect on cancer growth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IA BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Cancer Center
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out
- Can radiation replace surgery for cancer spread to lymph nodes?
- Genetic roadmaps for advanced cancer: study tests whether expert navigation boosts targeted therapy use
- Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
- Major trial pits three chemo drugs against each other for advanced breast cancer
- Immunotherapy-Chemo cocktail shows promise in tough breast cancer